DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 09:46:50 2024-06-28 EDT | ||
| 0.72 EUR | 0.00% |
|
| Current month | -12.20% | ||
| 1 month | -7.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.72 | 0.00% |
| 24-06-27 | 0.72 | 0.00% |
| 24-06-26 | 0.72 | +7.46% |
| 24-06-25 | 0.67 | -1.47% |
| 24-06-24 | 0.68 | -9.33% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 09:46 am
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBM |
| ISIN | DE000HD4KBM1 |
| Date issued | 2024-04-11 |
| Strike | 285 $ |
| Maturity | 2025-03-19 (264 Days) |
| Parity | 10 : 1 |
| Emission price | 1.26 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.27 € |
|---|---|
| Lowest since issue | 0.65 € |
| Spread | 0.01 € |
| Spread % | 1.41% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
313.7
USD
Average target price
316.4
USD
Spread / Average Target
+0.88%
- Stock Market
- Certificates
- Certificat
